tiprankstipranks
Trending News
More News >
Indaptus Therapeutics (INDP)
NASDAQ:INDP
US Market

Indaptus Therapeutics (INDP) Financial Statements

Compare
568 Followers

Indaptus Therapeutics Financial Overview

Indaptus Therapeutics's market cap is currently $3.81M. The company's EPS TTM is $-3.743; its P/E ratio is -0.13; Indaptus Therapeutics is scheduled to report earnings on March 12, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -19.83M$ -15.37M$ -16.38M$ -14.91M$ -7.73M
EBITDA$ -19.83M$ -15.37M$ -16.38M$ -14.91M$ -7.73M
Net Income$ -20.85M$ -15.02M$ -15.42M$ -14.32M$ -7.71M
Balance Sheet
Cash & Short-Term Investments$ 8.51M$ 5.79M$ 13.36M$ 26.43M$ 39.13M
Total Assets$ 9.31M$ 7.34M$ 14.92M$ 28.06M$ 40.58M
Total Debt$ 0.00$ 84.16K$ 175.05K$ 80.49K$ 169.33K
Net Debt$ -8.51M$ -5.70M$ -13.19M$ -9.55M$ -38.96M
Total Liabilities$ 6.16M$ 3.39M$ 2.85M$ 3.43M$ 4.68M
Stockholders' Equity$ 3.15M$ 3.94M$ 12.08M$ 24.63M$ 35.90M
Cash Flow
Free Cash Flow$ -14.82M$ -12.32M$ -13.41M$ -13.25M$ -11.29M
Operating Cash Flow$ -14.82M$ -12.32M$ -13.41M$ -13.08M$ -11.29M
Investing Cash Flow$ 0.00$ 0.00$ 17.14M$ -16.43M$ 447.75K
Financing Cash Flow$ 17.54M$ 4.75M$ 0.00$ 0.00$ 48.34M
Currency in USD

Indaptus Therapeutics Earnings and Revenue History

Indaptus Therapeutics Debt to Assets

Indaptus Therapeutics Cash Flow

Indaptus Therapeutics Forecast EPS vs Actual EPS